All practice questions

8270 questions

Question 2641Question →

A 24-year-old man presents to the clinic for a routine wellness examination and sexual health screening. He reports having multiple male sexual partners and inconsistent condom use. He currently feels well and has no acute symptoms. The physician decides to screen him for human immunodeficiency virus (HIV). Assuming the patient has an acute HIV-1 infection, arrange the following laboratory evaluation steps in the correct chronological sequence according to the standard diagnostic algorithm.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Fourth-generation combination immunoassay, 2) Antibody differentiation immunoassay, 3) HIV-1 nucleic acid test (NAT), and 4) Baseline CD4 cell count and viral load.
The standard HIV diagnostic algorithm dictates starting with a highly sensitive screening test (4th-generation antigen/antibody immunoassay). If reactive, it is followed by a highly specific confirmatory test (HIV-1/2 antibody differentiation immunoassay). In acute HIV, the screening test is reactive due to the presence of the p24 antigen, but the differentiation assay is negative because antibodies have not yet seroconverted. This discordant result requires an HIV-1 NAT to confirm acute infection. Finally, after confirmation, baseline laboratory values (CD4 count and viral load) are drawn to guide treatment.

Step-by-Step Solution

1
Identify the recommended initial screening test.
A fourth-generation HIV-1/2 antigen/antibody combination immunoassay is performed.
This is the most sensitive initial test because it detects both the p24 antigen (present early in acute infection) and HIV antibodies.
2
Determine the next step following a reactive screening test.
An HIV-1/HIV-2 antibody differentiation immunoassay is performed.
A reactive initial screen must be confirmed. The differentiation assay distinguishes between HIV-1 and HIV-2 and confirms the presence of antibodies.
3
Resolve the indeterminate or negative confirmatory result seen in acute infection.
An HIV-1 nucleic acid test (NAT) is performed.
Because the patient has an acute infection, antibodies may not yet be present in sufficient quantities, making the differentiation assay negative. The NAT directly detects the viral RNA, confirming acute HIV-1.
4
Plan post-diagnostic management.
CD4 cell count and HIV RNA viral load are measured.
Once the diagnosis is confirmed, baseline immune and viral parameters must be established before or alongside initiating antiretroviral therapy.

Key Concept

The standard HIV diagnostic algorithm requires sequential testing: initial screening with a 4th-generation antigen/antibody assay, followed by an antibody differentiation assay if positive, and a nucleic acid test (NAT) if the differentiation assay is negative or indeterminate (which is characteristic of acute HIV infection).
Estimated Time:1m 0s
Question 2642Question →

A 1212-day-old female neonate is brought to the emergency department due to a 11-day history of fever, lethargy, and poor feeding. Physical examination reveals a cluster of intact and ruptured erythematous vesicles on the scalp at the site of a prior fetal scalp monitor. The neonate has a temperature of 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), a heart rate of 190/min190/\text{min}, a respiratory rate of 65/min65/\text{min}, and a blood pressure of 50/30 mm Hg50/30\text{ mm Hg}. The extremities are cool and mottled, with a capillary refill time of 55 seconds. Based on the clinical presentation, arrange the following management steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Establish intravenous access and administer fluids, 2) Obtain blood/urine cultures and surface swabs, 3) Administer empiric IV acyclovir and antibiotics, 4) Perform a lumbar puncture once stable, and 5) Adjust therapy based on definitive PCR/culture results.
The correct chronological management of a neonate in septic shock with suspected HSV prioritizes physiological stabilization over invasive diagnostics. The first step is addressing airway, breathing, and circulation via intravenous fluids. The second step involves gathering non-invasive cultures (blood, surface swabs) rapidly so that the third step, the administration of life-saving empiric antibiotics and acyclovir, is not delayed. The fourth step, the lumbar puncture, is critical for defining the extent of HSV infection but must be postponed until the neonate is hemodynamically stable to prevent acute cardiorespiratory decompensation. Finally, the fifth step represents the definitive tailored therapy based on the results of the deferred diagnostics.

Step-by-Step Solution

1
Recognize septic shock and signs of neonatal HSV.
The neonate is hemodynamically unstable (shock) and has a classic vesicular rash indicating herpes simplex virus.
Identifying hemodynamic instability dictates that physiological resuscitation must precede invasive diagnostic procedures like a lumbar puncture.
2
Prioritize resuscitation and non-invasive diagnostics.
The sequence begins with IV access and fluids, followed immediately by drawing blood cultures and swabs.
Circulation must be restored first. Non-invasive cultures must precede antimicrobials to avoid sterilizing the samples.
3
Initiate empiric pharmacotherapy without delay.
Administer intravenous acyclovir combined with broad-spectrum antibiotics.
Neonatal HSV and bacterial sepsis can be rapidly fatal; life-saving therapy cannot wait for imaging or a lumbar puncture.
4
Complete invasive diagnostics safely.
Perform the lumbar puncture only after the infant is physiologically stabilized.
Performing a lumbar puncture in an actively crashing neonate risks respiratory arrest and brain herniation.
5
Tailor definitive management.
Adjust antimicrobial therapy based on final PCR and culture results.
Disseminated or central nervous system HSV requires 2121 days of acyclovir, whereas isolated skin, eye, and mouth (SEM) disease requires 1414 days.

Key Concept

In an unstable neonate with suspected HSV and sepsis, hemodynamic stabilization and empiric antimicrobials (including acyclovir) must take priority and precede a lumbar puncture.
Estimated Time:1m 30s
Question 2643Question →

During a mid-December clinic visit, a 5-month-old female infant is evaluated for a cough and rapid breathing. The mother reports that the infant developed sneezing and a runny nose four days ago. Since yesterday, the cough has worsened. Vital signs include a temperature of 37.6°C (99.7°F), heart rate of 135/min, respiratory rate of 56/min, and oxygen saturation of 97% on room air. The infant is alert and feeding well. Lung auscultation reveals scattered end-expiratory wheezes and mild intercostal retractions bilaterally. Which of the following is the most appropriate management for this patient?

Show answer & explanation

Answer: Observation and reassurance regarding adequate fluid intake

Answer

Observation and reassurance regarding adequate fluid intake
This patient presents with classic signs of mild viral bronchiolitis (rhinorrhea, low-grade fever, wheezing, and mild work of breathing in an infant during winter). Because she is well-hydrated and maintaining normal oxygen saturation on room air, the standard of care is entirely supportive, focusing on maintaining adequate hydration and monitoring.

Step-by-Step Solution

1
Analyze the patient's age and clinical presentation.
A 5-month-old infant in winter with an upper respiratory prodrome progressing to wheezing and mild retractions.
To establish the most likely clinical diagnosis based on the seasonal pattern and symptomatology.
2
Identify the disease entity.
The constellation of findings is classic for acute viral bronchiolitis, most commonly caused by respiratory syncytial virus (RSV).
Bronchiolitis is a clinical diagnosis primarily affecting infants under 2 years of age.
3
Determine the appropriate severity and management.
The patient has normal oxygen saturation (>90%) and is feeding well despite mild retractions. Management is supportive.
Mild bronchiolitis does not require pharmacologic intervention or routine imaging.

Key Concept

Diagnosis and management of mild acute viral bronchiolitis in infants.
Question 2644Question →

A 4-year-old boy is brought to the clinic for a routine health maintenance evaluation. He was born at 39 weeks gestation via uncomplicated spontaneous vaginal delivery. Four weeks ago, he was diagnosed with minimal change disease and was started on oral prednisone at 2 mg/kg/day. He has been taking the medication continuously since then with significant improvement in his edema. His mother brings up a concern regarding his development; she notes that he can hop on one foot, copy a cross, and play cooperatively with other children, but he is unable to skip on one foot or tie his shoelaces. Vital signs today are within normal limits for his age. Physical examination reveals mild cushingoid features but is otherwise unremarkable. A review of his immunization record shows he received all recommended vaccines up to age 2 years. He is currently scheduled to receive his standard kindergarten booster vaccines. Which of the following is the most appropriate management for this patient today?

Show answer & explanation

Answer: Provide diphtheria, tetanus, and acellular pertussis (DTaP) and inactivated poliovirus (IPV) vaccines only; provide developmental reassurance

Answer

Provide diphtheria, tetanus, and acellular pertussis (DTaP) and inactivated poliovirus (IPV) vaccines only; provide developmental reassurance
The correct management is to administer only the inactivated vaccines (DTaP and IPV) and reassure the mother regarding the child's development. This patient is receiving high-dose systemic corticosteroids (prednisone at ≥\ge 2 mg/kg/day for ≥\ge 14 consecutive days), which induces profound immunosuppression. Under these conditions, live-attenuated vaccines, such as MMR and varicella, are strictly contraindicated due to the risk of vaccine-strain infection. These live vaccines should be deferred until the patient has been off high-dose steroids for at least 1 month. Conversely, inactivated vaccines (such as DTaP and IPV) are safe and should be administered according to the schedule, even though the immune response may be blunted. Regarding development, a healthy 4-year-old is expected to hop on one foot, copy a cross, and play cooperatively. The abilities to skip on alternate feet and tie shoelaces typically emerge around age 5. Therefore, the child is meeting appropriate milestones, and the mother should simply be reassured.

Step-by-Step Solution

1
Assess the patient's immune status based on current medications.
The patient is on high-dose systemic corticosteroids (2 mg/kg/day of prednisone for >14 days).
High-dose steroid therapy causes significant immunosuppression, altering standard vaccine safety protocols.
2
Determine which of the scheduled vaccines can be safely administered.
DTaP and IPV are inactivated and can be given. MMR and Varicella are live-attenuated and must be deferred.
Live-attenuated vaccines are strictly contraindicated in severely immunocompromised patients due to the risk of uncontrolled viral replication.
3
Evaluate the mother's developmental concerns against age-appropriate milestones.
Hopping on one foot and copying a cross are normal 4-year-old milestones. Skipping and tying shoelaces are expected at age 5.
Identifying that the child's development is entirely normal indicates that reassurance, rather than referral, is the correct action.

Key Concept

Immunization contraindications in immunocompromised pediatric patients and normal preschool developmental milestones.
Question 2645Question →

A 55-year-old boy is brought to the emergency department due to a 2424-hour history of high fever and refusal to walk. His temperature is 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), heart rate is 118/min118/\text{min}, respiratory rate is 22/min22/\text{min}, and blood pressure is 105/65 mm Hg105/65\text{ mm Hg}. Physical examination reveals that the right hip is held in flexion, abduction, and external rotation. Any passive movement of the right hip elicits severe pain and crying. The patient is hemodynamically stable and appears well-perfused. Arrange the following steps in the most appropriate chronological sequence for the evaluation and management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Obtain blood cultures and inflammatory markers, 2) Perform ultrasonography of the hips, 3) Perform diagnostic arthrocentesis, 4) Administer empiric intravenous antibiotics, 5) Perform urgent surgical irrigation and debridement.
The management of pediatric septic arthritis requires a precise, sequential approach to ensure accurate diagnosis while preserving joint function. In a hemodynamically stable patient, initial evaluation begins with obtaining inflammatory markers (ESR, CRP, WBC) and blood cultures to apply the Kocher criteria and screen for bacteremia. Because the hip is a deep structure, ultrasonography is the preferred rapid imaging modality to confirm the presence of a joint effusion. Once an effusion is identified, diagnostic arthrocentesis must be performed to obtain synovial fluid for cell count, Gram stain, and culture. It is a critical tenet of infectious disease management that, in the absence of hemodynamic instability or sepsis, source fluid must be obtained prior to the administration of antibiotics to avoid sterilizing the culture. After synovial fluid is secured, empiric intravenous antibiotics are immediately initiated. Finally, if purulent fluid is confirmed, the patient requires urgent surgical irrigation and debridement to decompress the joint, thereby preventing irreversible cartilage damage and avascular necrosis of the femoral head.

Step-by-Step Solution

1
Obtain blood cultures, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR).
Establishes baseline markers and assesses for systemic bacteremia.
Applying the Kocher criteria requires inflammatory markers, and blood cultures should be drawn concurrently with initial intravenous access.
2
Perform ultrasonography of the bilateral hips.
Confirms the presence of a joint effusion in the right hip.
The hip is a deep joint, and an effusion must be visually confirmed prior to attempting an invasive needle aspiration.
3
Perform diagnostic arthrocentesis of the affected joint.
Obtains synovial fluid for cell count, Gram stain, and culture.
Definitive diagnosis requires synovial fluid analysis. Crucially, this must be performed before antibiotic administration in a stable patient to prevent sterilizing the culture.
4
Administer empiric intravenous vancomycin and ceftriaxone.
Initiates targeted antimicrobial therapy against organisms like Staphylococcus aureus and Streptococcus species.
Antibiotics should be given promptly after the source fluid is secured to prevent further joint destruction and systemic spread.
5
Perform urgent surgical irrigation and debridement.
Evacuates purulent material and decompresses the joint space.
Reduces the bacterial load and prevents increased intra-articular pressure, which can lead to irreversible avascular necrosis of the femoral head.

Key Concept

In a hemodynamically stable child with suspected septic arthritis, diagnostic arthrocentesis must be performed after confirming an effusion but strictly before the administration of empiric antibiotics to ensure accurate pathogen identification.
Question 2646Question →

A 66-month-old boy is brought to the pediatric clinic by his parents due to a worsening cough. For the past week, he had a mild runny nose and low-grade fever. Over the last 4848 hours, the cough has become severe, occurring in intense spasms. The parents note that he occasionally vomits immediately after these coughing spells and his face turns red during the episodes. He has only received his first set of immunizations at 22 months of age due to parental hesitancy. His temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 90/55 mmHg90/55\text{ mmHg}, pulse is 135/min135/\text{min}, and respirations are 42/min42/\text{min}. Pulse oximetry shows 98%98\% on room air. The patient appears comfortable and playful in the examination room. Cardiopulmonary examination reveals clear lungs bilaterally without crackles or wheezes. Laboratory testing shows a leukocyte count of 24,000/mm324,000/\text{mm}^3 with 78%78\% lymphocytes. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Prescribe oral azithromycin

Answer

Prescribe oral azithromycin
The patient's clinical presentation—intense coughing spasms, post-tussive emesis, facial plethora during episodes, and marked lymphocytosis—in the setting of incomplete immunizations is classic for Bordetella pertussis infection. The paroxysmal stage typically follows a 1- to 2-week catarrhal phase (mild URI symptoms). Azithromycin (or another macrolide) is the first-line treatment. Although antibiotic therapy initiated during the paroxysmal phase may not significantly alter the clinical course of the disease, it is critical for eradicating the bacteria from the nasopharynx, thereby decreasing infectivity and preventing transmission to others. Because the infant is well-appearing between spells and maintains normal oxygenation on room air, outpatient management with oral antibiotics is safe and appropriate.

Step-by-Step Solution

1
Analyze the clinical presentation and immunization history.
The patient is an under-immunized 6-month-old infant with a paroxysmal cough, post-tussive emesis, and marked lymphocytosis.
These classic findings strongly suggest an infection with Bordetella pertussis (whooping cough).
2
Assess the severity of the illness.
The infant is well-appearing between coughing fits, has normal vital signs for his age, and maintains normal oxygen saturation on room air.
This indicates that the patient is hemodynamically and clinically stable enough for outpatient management rather than requiring hospital admission.
3
Determine the appropriate pharmacotherapy.
Select a macrolide antibiotic such as azithromycin.
Macrolides are the first-line treatment for pertussis. They eradicate the organism from the nasopharynx to prevent transmission and, if given early enough, may reduce the duration of symptoms.

Key Concept

Diagnosis and management of Bordetella pertussis in an incompletely immunized infant
Question 2647Question →

Parents bring their 33-year-old daughter to an urgent care center in late autumn after she developed a sudden high fever and a persistent, productive cough over the past 4848 hours. The parents report that she has been significantly less active and is breathing more rapidly than usual since waking up this morning. Her past medical history is unremarkable, and she has received all standard childhood immunizations except for her seasonal vaccines this year. Her temperature is 39.5∘C39.5^\circ\text{C} (103.1∘F103.1^\circ\text{F}), pulse is 135/min135/\text{min}, and respiratory rate is 44/min44/\text{min}. Pulse oximetry is 96%96\% on room air. Physical examination reveals an ill-appearing, fatigued child. Lung auscultation demonstrates focal fine crackles and decreased breath sounds localized to the right lower lung field. No wheezing, rhonchi, or stridor is appreciated. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Prescribe oral amoxicillin

Answer

Prescribe oral amoxicillin
The correct action is to prescribe oral amoxicillin. This patient's presentation of a sudden-onset high fever, tachypnea, and focal lung examination findings (crackles and decreased breath sounds) is classic for typical community-acquired pneumonia (CAP). In children between the ages of 6 months and 5 years, the most common bacterial etiology of typical CAP is *Streptococcus pneumoniae*. Clinical guidelines strongly recommend high-dose oral amoxicillin as the first-line empiric outpatient therapy, as it provides excellent coverage against *S. pneumoniae* and adheres to principles of antibiotic stewardship.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient is a 3-year-old with acute onset of high fever (39.5∘C39.5^\circ\text{C}), tachypnea (44/min44/\text{min}), and localized crackles in the right lower lung field.
Identifying the acuity, signs of respiratory distress, and focal lung findings distinguishes this condition from diffuse viral processes.
2
Formulate a diagnosis based on the clinical findings.
The localized crackles, tachypnea, and sudden high fever point directly to typical community-acquired pneumonia (CAP).
Focal alveolar consolidation manifests as crackles and decreased breath sounds, hallmarking a bacterial pneumonia rather than viral bronchiolitis or asthma.
3
Determine the most likely pathogen and the appropriate empiric treatment for the patient's age group.
In preschool-aged children (66 months to 55 years), the most common bacterial cause of typical CAP is Streptococcus pneumoniae. The first-line outpatient treatment is high-dose oral amoxicillin.
Antibiotic stewardship dictates using narrow-spectrum agents tailored to the most likely organism. High-dose amoxicillin provides excellent coverage against S. pneumoniae.

Key Concept

First-line empiric treatment for typical community-acquired pneumonia in preschool-aged children
Question 2648Question →

A 4848-year-old man presents to the oncology unit with a temperature of 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}) and rigors. He is currently on day 1010 of induction chemotherapy for acute myeloid leukemia (AML). Vital signs are pulse 118 /min118\text{ /min}, blood pressure 95/60 mmHg95/60\text{ mmHg}, and respirations 22 /min22\text{ /min}. He has an indwelling central venous catheter with no surrounding erythema or purulence. Laboratory studies demonstrate a hemoglobin of 8.5 g/dL8.5\text{ g/dL}, platelets of 45,000/μL45,000/\mu\text{L}, and an absolute neutrophil count (ANC) of 100/μL100/\mu\text{L}.

Arrange the following management steps in the optimal chronological sequence for this patient according to standard oncologic guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential management of high-risk febrile neutropenia is: 1) Draw blood cultures, 2) Initiate empiric anti-pseudomonal beta-lactams, 3) Tailor therapy based on culture results, 4) Add empiric antifungals if fever persists for 4 to 7 days, and 5) Discontinue therapy upon ANC recovery and defervescence.
The sequence strictly follows the IDSA and ASCO guidelines for managing febrile neutropenia, which is considered a life-threatening oncologic emergency. Securing pathogen samples via blood cultures is the immediate priority to prevent sterilization by antibiotics. However, this must not significantly delay the administration of an anti-pseudomonal beta-lactam, which must occur within 60 minutes of presentation. Once preliminary culture data is obtained, the broad-spectrum regimen is narrowed to optimize efficacy. In high-risk, profoundly neutropenic patients, prolonged fever (beyond 4 to 7 days) despite targeted bacterial coverage strongly suggests an occult invasive fungal infection, prompting the addition of an empiric antifungal agent. Finally, safely discontinuing antimicrobial therapy relies on evidence of functional immune recovery, specifically an absolute neutrophil count exceeding 500/μL accompanied by clinical defervescence.

Step-by-Step Solution

1
Draw peripheral and central venous blood cultures
Secures diagnostic samples before pathogen eradication
Antibiotics rapidly sterilize the blood; obtaining cultures first ensures accurate identification of the causative organism.
2
Initiate empiric anti-pseudomonal beta-lactam therapy
Provides immediate broad-spectrum bacterial coverage
Neutropenic patients can rapidly deteriorate from sepsis, particularly from Pseudomonas aeruginosa, requiring administration of antibiotics within 60 minutes of presentation.
3
Tailor antimicrobial regimen based on culture data
Narrows or adjusts coverage for identified pathogens
Once the pathogen is identified, adjusting the regimen optimizes treatment efficacy and minimizes the risk of developing antimicrobial resistance.
4
Add empiric antifungal therapy if fever persists > 4 to 7 days
Covers opportunistic fungal pathogens (e.g., Candida, Aspergillus)
Prolonged neutropenic fever despite broad-spectrum antibiotics is a strong clinical indicator of an occult fungal infection.
5
Discontinue antimicrobial therapy upon recovery
Safely concludes the treatment course
Therapy is stopped once the patient demonstrates clinical stability (afebrile for 48 hours) and functional immune recovery (ANC > 500/μL).

Key Concept

The management of high-risk febrile neutropenia requires immediate blood cultures followed by an anti-pseudomonal beta-lactam, subsequent tailoring based on microbiologic data, addition of empiric antifungals for prolonged fever, and continuation of therapy until neutrophil recovery.
Estimated Time:1m 30s
Question 2649Question →

During a busy winter shift in early February, parents bring their 77-month-old son to the pediatric clinic. They report a 33-day history of nasal congestion, mild cough, and a low-grade fever. This morning, the infant developed rapid breathing and increased respiratory effort. He was born at term and has no significant past medical history. Vital signs show a temperature of 37.7∘C37.7^\circ\text{C} (99.9∘F99.9^\circ\text{F}), a heart rate of 145/min145/\text{min}, a respiratory rate of 58/min58/\text{min}, and an oxygen saturation of 95%95\% on room air. The physical examination is notable for copious clear rhinorrhea, mild subcostal retractions, and diffuse expiratory wheezing heard in all lung fields. What is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Supportive care with oral hydration and nasal suctioning

Answer

Supportive care with oral hydration and nasal suctioning
The clinical picture of a 77-month-old infant with a viral prodrome followed by wheezing and increased work of breathing during the winter is classic for acute bronchiolitis. The disease is typically self-limiting. The cornerstone of management for bronchiolitis in a well-oxygenated infant (>90%>90\%) without severe distress is supportive care, which primarily includes maintaining adequate hydration and relieving upper airway obstruction with saline drops and nasal suctioning.

Step-by-Step Solution

1
Identify the clinical syndrome based on patient age, season, and physical exam findings.
The 77-month-old infant presenting with rhinorrhea followed by wheezing, tachypnea, and retractions during winter has acute viral bronchiolitis, most commonly caused by Respiratory Syncytial Virus (RSV).
Pattern recognition is the first step in diagnosing classic pediatric respiratory infections.
2
Determine the severity of the illness and the need for hospitalization.
The patient is maintaining adequate oxygenation (95%95\% on room air) and has only mild retractions, indicating mild-to-moderate bronchiolitis without impending respiratory failure.
Severity dictates the setting of care (outpatient vs. inpatient) and the need for advanced respiratory support.
3
Select the most appropriate evidence-based management.
Supportive care focusing on fluid intake and relief of nasal congestion is the only indicated intervention.
Clinical guidelines strongly recommend against the routine use of bronchodilators, systemic corticosteroids, and antibiotics for typical bronchiolitis.

Key Concept

Diagnosis and management of acute viral bronchiolitis in infants.
Question 2650Question →

A 28-year-old man is found unresponsive in his bedroom by his roommate. Emergency medical services are called and he is brought to the hospital. He has a known past medical history of type 1 diabetes mellitus and major depressive disorder. On arrival, his temperature is 37.0°C (98.6°F), blood pressure is 105/65 mm Hg, pulse is 112/min, and respiratory rate is 12/min. Oxygen saturation is 92% on room air. Physical examination reveals a lethargic patient who only groans in response to sternal rub. His mucous membranes are notably dry. Pupillary examination reveals 2 mm pupils bilaterally that are sluggish to react to light.

Laboratory results are obtained:

Serum ChemistryResultReference Range
Sodium138 mEq/L136-145 mEq/L
Potassium4.5 mEq/L3.5-5.0 mEq/L
Chloride102 mEq/L95-105 mEq/L
Bicarbonate8 mEq/L22-28 mEq/L
Glucose520 mg/dL70-110 mg/dL
Arterial Blood Gas (Room Air)ResultReference Range
pH7.057.35-7.45
PaCO2PaCO_230 mm Hg35-45 mm Hg
PaO2PaO_265 mm Hg75-105 mm Hg

Which of the following best describes this patient's acid-base status?

Show answer & explanation

Answer: Primary elevated anion gap metabolic acidosis and primary respiratory acidosis

Answer

The patient has a primary elevated anion gap metabolic acidosis and a concurrent primary respiratory acidosis.
The correct answer accurately identifies the presence of two primary acid-base disorders. The patient's presentation of acidemia (pH 7.05) with a low bicarbonate (8 mEq/L) defines a primary metabolic acidosis. The anion gap is calculated as 138−(102+8)=28138 - (102 + 8) = 28 mEq/L. Since this is greater than the normal value of 12 mEq/L, an elevated anion gap metabolic acidosis is present. To assess if the respiratory response is adequate, Winter's formula is used: Expected PaCO2=1.5×HCO3−+8±2PaCO_2 = 1.5 \times HCO_3^- + 8 \pm 2. For this patient, Expected PaCO2=1.5×8+8=20±2PaCO_2 = 1.5 \times 8 + 8 = 20 \pm 2 mm Hg. The patient's actual PaCO2PaCO_2 is 30 mm Hg, which is significantly higher than the expected range of 18-22 mm Hg. When actual PaCO2PaCO_2 exceeds the expected PaCO2PaCO_2, it signifies inadequate ventilation and a superimposed primary respiratory acidosis. Clinically, this patient has diabetic ketoacidosis (causing the high anion gap metabolic acidosis) complicated by an opiate overdose (evidenced by lethargy, 2 mm pupils, and a relative bradypnea of 12/min instead of the expected Kussmaul respirations), which is causing the concurrent respiratory acidosis.

Step-by-Step Solution

1
Determine the primary acid-base disturbance using the pH and bicarbonate.
The pH is 7.05 (acidemia) and bicarbonate is 8 mEq/L (low).
This establishes that the primary disorder is a metabolic acidosis.
2
Calculate the anion gap to classify the metabolic acidosis.
Anion gap = Sodium - (Chloride + Bicarbonate) = 138 - (102 + 8) = 28 mEq/L.
An anion gap > 12 mEq/L indicates the presence of unmeasured anions, confirming an elevated anion gap metabolic acidosis (likely diabetic ketoacidosis given the severe hyperglycemia).
3
Apply Winter's formula to determine the expected respiratory compensation.
Expected PaCO2PaCO_2 = 1.5 × 8 + 8 ± 2 = 20 ± 2 mm Hg (Range: 18-22 mm Hg).
This calculates the physiological ventilatory response (decrease in carbon dioxide) expected for a given bicarbonate drop.
4
Compare the actual PaCO2 to the expected PaCO2 to check for mixed respiratory disorders.
Actual PaCO2PaCO_2 (30 mm Hg) is greater than the Expected PaCO2PaCO_2 (20 ± 2 mm Hg).
Because the actual PaCO2 is higher than expected, the patient is hypoventilating relative to the metabolic demand, indicating a superimposed primary respiratory acidosis (clinically supported by miosis and a relative bradypnea from suspected opiate intoxication).
5
Calculate the delta-delta ratio to rule out additional metabolic disturbances.
ΔAG=28−12=16\Delta AG = 28 - 12 = 16. ΔHCO3−=24−8=16\Delta HCO_3^- = 24 - 8 = 16. Ratio = 16 / 16 = 1.
A ratio of approximately 1 to 2 indicates a pure elevated anion gap metabolic acidosis without a hidden metabolic alkalosis or non-anion gap metabolic acidosis.

Key Concept

In mixed acid-base disorders, Winter's formula must be used to evaluate if respiratory compensation is appropriate; an actual PaCO2 higher than the calculated expected value indicates a concurrent primary respiratory acidosis.
Question 2651Question →

During morning rounds, a 30-year-old nulligravid patient is evaluated for discharge planning. She was admitted to the general medical ward 48 hours ago for acute pyelonephritis and was started on empiric intravenous ceftriaxone. She has shown rapid clinical improvement; she is now afebrile, her right-sided costovertebral angle tenderness has completely resolved, and she is eating a regular diet without nausea. The urine culture collected at admission grew >100,000>100,000 CFU/mL of *Escherichia coli*. The susceptibility report is as follows:

AntimicrobialInterpretation
CephalexinSusceptible
CiprofloxacinSusceptible
NitrofurantoinSusceptible
Trimethoprim-sulfamethoxazoleResistant

Based on principles of antimicrobial stewardship, which of the following is the most appropriate next step in pharmacological management?

Show answer & explanation

Answer: Transition to oral cephalexin

Answer

Transition to oral cephalexin
This patient presented with acute pyelonephritis and has rapidly improved on empiric intravenous antibiotics. Because she is afebrile, clinically stable, and tolerating an oral diet, she is an excellent candidate for step-down therapy to oral antibiotics. According to the principles of antimicrobial stewardship, definitive therapy should utilize the narrowest-spectrum agent that is effective and has appropriate tissue penetration for the site of infection. Cephalexin, a first-generation cephalosporin, perfectly fits these criteria: it provides targeted coverage against the susceptible E. coli isolate and achieves excellent concentrations in the renal parenchyma.

Step-by-Step Solution

1
Evaluate the patient's clinical trajectory and current stability.
The patient is afebrile, her pain has resolved, and she tolerates oral intake, indicating readiness for transition from intravenous to oral antibiotics.
Intravenous to oral step-down therapy reduces hospital length of stay and avoids line-associated complications in clinically stable patients.
2
Analyze the urine culture susceptibility report.
The pathogen is susceptible to cephalexin, ciprofloxacin, and nitrofurantoin, but resistant to trimethoprim-sulfamethoxazole.
Guiding definitive therapy based on culture results ensures eradication while minimizing resistance.
3
Select the most appropriate oral agent based on site of infection and antimicrobial stewardship principles.
Cephalexin is selected because it is a narrow-spectrum oral agent with excellent renal tissue penetration.
Nitrofurantoin cannot be used for upper urinary tract infections, and ciprofloxacin is overly broad when a first-generation cephalosporin is effective.

Key Concept

In patients with acute pyelonephritis who demonstrate clinical improvement and tolerate oral intake, intravenous antibiotics should be transitioned to the narrowest-spectrum effective oral agent based on culture susceptibility.
Estimated Time:1m 0s
Question 2652Question →

A 34-year-old previously healthy man presents to the outpatient clinic complaining of a painful swelling on his right posterior thigh that began 3 days ago. He has no significant past medical history and takes no medications. His temperature is 37.0°C (98.6°F), blood pressure is 122/78 mmHg, pulse is 76/min, and respiratory rate is 14/min. Physical examination reveals a 2.5-cm, exquisitely tender, fluctuant, erythematous nodule. There is less than 1 cm of surrounding erythema and no regional lymphadenopathy. A point-of-care ultrasound confirms a localized fluid collection with no deep tissue tracking. The physician performs an uncomplicated bedside incision and drainage, yielding approximately 10 mL of opaque, yellow purulent material. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Local wound care without systemic antimicrobial therapy

Answer

Local wound care without systemic antimicrobial therapy is the correct management, as incision and drainage alone is curative for simple abscesses in healthy patients.
The correct management for a mild, purulent skin and soft tissue infection (such as a simple abscess) in an immunocompetent patient without systemic signs of illness (fever, tachycardia, tachypnea) is incision and drainage followed by local wound care. Systemic antimicrobial therapy provides minimal to no additional clinical benefit in this specific population once adequate source control is achieved. Withholding antibiotics in this scenario is a core tenet of antimicrobial stewardship.

Step-by-Step Solution

1
Evaluate the patient's clinical stability and immune status.
The patient is young, previously healthy, and has entirely normal vital signs without systemic inflammatory response syndrome (SIRS).
Determines whether the infection is classified as mild, moderate, or severe.
2
Assess the characteristics of the skin and soft tissue infection (SSTI).
It is a purulent infection (abscess) that is localized (2.5 cm) with minimal surrounding cellulitis.
Differentiates purulent from non-purulent SSTIs, which guides both mechanical and pharmacological management.
3
Apply infectious disease guidelines for mild purulent SSTIs.
Current guidelines recommend incision and drainage alone for simple abscesses in immunocompetent patients without systemic signs.
Ensures appropriate antimicrobial stewardship by avoiding unnecessary antibiotic exposure.

Key Concept

Antimicrobial stewardship in the management of mild, purulent skin and soft tissue infections (simple cutaneous abscesses).
Question 2653Question →

A woman, aged 48, is brought to the acute care clinic by her husband due to a 3-day history of worsening shortness of breath, severe headache, and blurry vision. She has known diagnoses of diffuse cutaneous systemic sclerosis and hypothyroidism, for which she takes mycophenolate mofetil and levothyroxine. Her temperature is 37.1°C (98.8°F), blood pressure is 225/115 mm Hg, heart rate is 108/min, and respiratory rate is 26/min. Oxygen saturation is 91% on ambient air. Physical examination reveals thickened, tight skin over the face, trunk, and proximal extremities. Funduscopic examination shows bilateral flame-shaped hemorrhages. Cardiopulmonary auscultation reveals bilateral basilar crackles and a loud S2S_2. There is 2+ pitting edema of the lower extremities.

Laboratory evaluations show:
- Hemoglobin: 8.4 g/dL
- Platelets: 85,000/mm 3^3
- Leukocytes: 11,500/mm 3^3
- Serum creatinine: 3.2 mg/dL (baseline was 0.9 mg/dL two months ago)
- Blood urea nitrogen: 48 mg/dL
- TSH: 2.5 μ\mu U/mL (Reference: 0.4-4.0 μ\mu U/mL)
- Free T4: 0.5 ng/dL (Reference: 0.9-1.7 ng/dL)
- Peripheral blood smear: 3-5 schistocytes per high-power field
- Arterial blood gas (ambient air): pH 7.32, pCO2pCO_2 30 mm Hg, pO2pO_2 65 mm Hg, HCO3−HCO_3^- 15 mEq/L

Which of the following interventions is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate oral captopril therapy

Answer

Initiate oral captopril therapy
The patient's presentation of malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia in the setting of diffuse cutaneous systemic sclerosis is highly characteristic of scleroderma renal crisis (SRC). SRC is precipitated by renal vascular injury leading to severe ischemia and a massive surge in renin production. The first-line, life-saving treatment is the rapid initiation of an angiotensin-converting enzyme (ACE) inhibitor, typically captopril, to directly counteract the renin-angiotensin-aldosterone system (RAAS) hyperactivation. Even in the presence of acute kidney injury, ACE inhibitors must be started and titrated to control blood pressure.

Step-by-Step Solution

1
Identify the primary clinical syndrome based on the patient's history and presentation.
The patient has systemic sclerosis and presents with new-onset malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia (schistocytes, thrombocytopenia).
This triad of findings in a patient with diffuse cutaneous systemic sclerosis establishes the diagnosis of scleroderma renal crisis (SRC).
2
Determine the underlying pathophysiology driving the acute crisis.
SRC is caused by intimal thickening of the renal arterioles leading to severe renal ischemia. This ischemia triggers massive activation of the renin-angiotensin-aldosterone system (RAAS).
Understanding that RAAS hyperactivation is the primary driver of the malignant hypertension is essential for selecting targeted pharmacotherapy.
3
Select the most appropriate evidence-based intervention.
An angiotensin-converting enzyme (ACE) inhibitor, such as short-acting captopril, must be initiated immediately.
ACE inhibitors directly block the RAAS cascade, reversing the primary pathophysiologic mechanism of SRC. They are life-saving and should be used even in the setting of acute kidney injury.

Key Concept

Scleroderma renal crisis presents with malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia. It is a life-threatening emergency that must be treated immediately with an ACE inhibitor (e.g., captopril) to reverse massive RAAS activation.
Question 2654Question →

A 6262-year-old woman arrives at the emergency department reporting fevers, chills, and profound fatigue over the past 1212 hours. She is currently undergoing multi-agent chemotherapy for diffuse large B-cell lymphoma; her last infusion was 1010 days ago. Her temperature is 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}), blood pressure is 112/72 mm Hg112/72\text{ mm Hg}, pulse is 95/min95\text{/min}, and respiratory rate is 16/min16\text{/min}. Physical examination reveals a totally implanted central venous access device in her right chest with no surrounding erythema, induration, or tenderness. Lungs are clear to auscultation. There are no skin rashes or oral ulcers.

Laboratory results are as follows:

Laboratory testResult
Hemoglobin8.8 g/dL8.8\text{ g/dL}
Platelets95,000/mm395,000\text{/mm}^3
Leukocytes600/mm3600\text{/mm}^3
Segmented neutrophils15%15\%
Band forms5%5\%
Creatinine1.1 mg/dL1.1\text{ mg/dL}
Total bilirubin0.9 mg/dL0.9\text{ mg/dL}

A chest radiograph shows no focal consolidation.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Obtain blood cultures and initiate intravenous cefepime

Answer

The most appropriate next step is to obtain blood cultures and immediately initiate intravenous cefepime.
The correct answer involves obtaining blood cultures and immediately starting an intravenous antipseudomonal beta-lactam, such as cefepime. Febrile neutropenia is a medical emergency defined by an absolute neutrophil count (ANC) of less than 500/mm3500\text{/mm}^3 and a single oral temperature of ≥38.3∘C\geq 38.3^\circ\text{C} (101.0∘F101.0^\circ\text{F}) or ≥38.0∘C\geq 38.0^\circ\text{C} (100.4∘F100.4^\circ\text{F}) sustained over 11 hour. This patient's ANC is 120/mm3120\text{/mm}^3 (600×0.20600 \times 0.20). Due to the high risk of rapid clinical deterioration from bacterial sepsis (particularly Pseudomonas aeruginosa), prompt initiation of empiric broad-spectrum intravenous antibiotics is mandated. Cefepime, meropenem, or piperacillin-tazobactam are the standard of care for high-risk patients.

Step-by-Step Solution

1
Calculate the Absolute Neutrophil Count (ANC).
ANC is 120/mm3120\text{/mm}^3 (Total Leukocytes 600×0.20600 \times 0.20 [segmented + bands]).
To confirm the presence of profound neutropenia, which is defined as an ANC less than 500/mm3500\text{/mm}^3.
2
Identify the clinical syndrome based on the presentation.
The patient has febrile neutropenia.
The patient has a single oral temperature of 38.9∘C38.9^\circ\text{C} concurrent with severe neutropenia.
3
Risk-stratify the patient to determine the appropriate treatment setting and route.
This is a high-risk presentation.
Patients with hematologic malignancies undergoing active multi-agent chemotherapy who develop profound neutropenia are automatically classified as high-risk and require inpatient intravenous management.
4
Select the appropriate empirical antimicrobial therapy.
Intravenous cefepime.
Guidelines mandate immediate empiric monotherapy with an antipseudomonal beta-lactam (e.g., cefepime, meropenem, or piperacillin-tazobactam). Additional coverage with vancomycin is not indicated because there is no hemodynamic instability, port infection, or severe mucositis.

Key Concept

High-risk febrile neutropenia is an oncologic emergency that requires immediate blood cultures followed by prompt initiation of an intravenous antipseudomonal beta-lactam.
Question 2655Question →

A 48-year-old woman comes to the emergency department complaining of a severe, throbbing headache, blurred vision, and mild shortness of breath that began 22 days ago. She has a 44-year history of diffuse cutaneous systemic sclerosis. Her home medications include mycophenolate mofetil and omeprazole. In the emergency department, her blood pressure is 220/125220/125 mmHg, pulse is 9898/min, and respiratory rate is 1818/min. Physical examination reveals tight, thickened skin over her face, trunk, and proximal extremities. Funduscopic examination shows bilateral papilledema and flame-shaped hemorrhages. Lung auscultation reveals bibasilar crackles.

Laboratory evaluation:
Hemoglobin: 8.98.9 g/dL
Platelets: 95,00095,000/mm 3^3
Creatinine: 2.72.7 mg/dL (baseline 0.80.8 mg/dL)
Peripheral blood smear: 3-4 schistocytes per high-power field

Which of the following is the most appropriate initial pharmacological treatment for this patient's current condition?

Show answer & explanation

Answer: Oral captopril

Answer

Oral captopril
The patient's presentation of malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia (schistocytes, thrombocytopenia) in the setting of diffuse cutaneous systemic sclerosis is classic for scleroderma renal crisis (SRC). SRC is caused by marked intimal proliferation of renal arterioles leading to decreased renal perfusion, which triggers massive activation of the renin-angiotensin-aldosterone system (RAAS). This creates a vicious cycle of severe hypertension and further renal vasoconstriction. The cornerstone of management is rapid RAAS blockade using a short-acting ACE inhibitor, specifically oral captopril. Importantly, ACE inhibitors must be initiated immediately, even in the setting of acute kidney injury and an elevated creatinine, as they uniquely reverse the underlying pathophysiologic mechanism and offer the best chance for renal recovery.

Step-by-Step Solution

1
Identify the primary diagnosis based on the clinical presentation and history.
The patient has systemic sclerosis and presents with malignant hypertension, acute kidney injury, and microangiopathic hemolytic anemia (MAHA), establishing the diagnosis of scleroderma renal crisis (SRC).
Recognizing the complication is essential to selecting the targeted therapy, as SRC management differs from generic hypertensive emergencies.
2
Determine the underlying pathophysiology driving the crisis.
SRC is driven by massive activation of the renin-angiotensin-aldosterone system (RAAS) causing severe renal vasoconstriction.
Understanding the mechanism dictates that the therapy must directly inhibit this pathway.
3
Select the appropriate pharmacotherapy to counteract the mechanism.
An angiotensin-converting enzyme (ACE) inhibitor, specifically captopril, is selected.
ACE inhibitors are uniquely effective in reversing the RAAS hyperactivation and are indicated even in the presence of acute kidney injury.

Key Concept

Scleroderma renal crisis presents with acute oliguric renal failure and malignant hypertension, and the first-line, life-saving treatment is immediate administration of an ACE inhibitor (captopril) regardless of the elevated serum creatinine.
Question 2656Question →

Maternity ward staff request a pediatric evaluation for an infant who has developed a new skin eruption. The infant was delivered vaginally two days ago at 3939 weeks gestation to a 2626-year-old primigravida. The mother has a history of recurrent genital herpes simplex virus (HSV) infections but had no active lesions or prodromal symptoms at the time of delivery. She received daily valacyclovir prophylaxis throughout the third trimester. Currently, the infant is afebrile, breastfeeding vigorously every 22 to 33 hours, and has age-appropriate wet diapers and stools. Physical examination reveals multiple scattered erythematous patches with 11- to 22-mm central yellowish pustules distributed widely over the chest, abdomen, and back. The palms and soles are completely spared. The infant has normal tone, an intact Moro reflex, and no hepatosplenomegaly. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Reassure the parents and continue routine newborn care

Answer

Reassure the parents and continue routine newborn care.
The correct answer involves reassuring the parents, as this infant is presenting with Erythema Toxicum Neonatorum (ETN). ETN is a benign, self-limited condition that occurs in up to 50%50\% of full-term neonates, typically appearing on days 22 to 33 of life. It is characterized by scattered erythematous macules with central 11- to 22-mm yellowish-white pustules, most prominently on the trunk and proximal extremities, while classically sparing the palms and soles. Because the infant is afebrile, feeding vigorously, and well-appearing, infectious etiologies are highly unlikely. A Wright or Giemsa stain of the pustules (if performed) would show numerous eosinophils, confirming the diagnosis, but clinical diagnosis is sufficient and no treatment other than reassurance is indicated.

Step-by-Step Solution

1
Evaluate the morphological characteristics of the neonatal rash.
The rash consists of erythematous patches with small central yellowish pustules, sparing the palms and soles.
Identifying the specific appearance of the rash is essential to distinguish between benign newborn eruptions and infectious etiologies.
2
Assess the clinical status of the neonate and maternal risk factors.
The infant is vigorous, afebrile, and feeding well. The mother has a history of HSV but was on prophylaxis without active lesions at delivery.
A well-appearing infant drastically lowers the suspicion for systemic infectious processes like early-onset sepsis or disseminated HSV.
3
Synthesize the findings to determine the correct diagnosis and management.
The clinical picture is diagnostic for Erythema Toxicum Neonatorum (ETN), necessitating no intervention.
ETN is a common, benign, self-limited condition that requires only reassurance.

Key Concept

Erythema toxicum neonatorum (ETN) is a benign, self-limited neonatal rash characterized by erythematous macules with central pustules that requires only reassurance, and must be distinguished from infectious rashes.
Question 2657Question →

A 2-month-old girl is brought to the clinic for a routine well-child visit. She was born at 39 weeks gestation via uncomplicated vaginal delivery. Her mother has severe Crohn disease and was treated with infliximab throughout the pregnancy. The infant is exclusively breastfed, feeds well, and is gaining weight appropriately. Her physical examination is unremarkable. She received the hepatitis B vaccine at birth. The pediatrician discusses the routine 2-month immunizations, which normally include the diphtheria, tetanus, and acellular pertussis (DTaP); Haemophilus influenzae type b (Hib); inactivated poliovirus (IPV); pneumococcal conjugate (PCV); and rotavirus vaccines. Based on this patient's history, which of the following is the most appropriate recommendation regarding her immunizations today?

Show answer & explanation

Answer: Withhold the rotavirus vaccine and administer the remaining routine vaccines.

Answer

Withhold the rotavirus vaccine and administer the remaining routine vaccines.
The correct recommendation is to withhold the rotavirus vaccine and administer all other routine 2-month vaccines. Infliximab is an IgG1 monoclonal antibody that actively crosses the placenta, particularly in the third trimester. Consequently, infants born to mothers receiving this biologic therapy are born with therapeutic serum levels of the drug, rendering them functionally immunocompromised for up to 6 months of age. According to the CDC, live-attenuated vaccines are contraindicated in these infants during this 6-month window due to the risk of uncontrolled vaccine-strain viral replication. Of the routine 2-month immunizations, only the rotavirus vaccine is live-attenuated. The other scheduled vaccines (DTaP, Hib, IPV, and PCV) are inactivated and are safe and highly recommended to prevent life-threatening childhood illnesses.

Step-by-Step Solution

1
Identify the maternal medication and its pharmacokinetic properties during pregnancy.
The mother took infliximab, an IgG1 monoclonal antibody targeting TNF-alpha.
IgG antibodies actively cross the placenta, primarily during the third trimester, providing passive immunity but also transferring any IgG-based medications.
2
Determine the clinical implication for the infant.
The infant is considered functionally immunocompromised.
Because infliximab crosses the placenta, the infant can have detectable serum levels of the immunosuppressive drug for up to 6 months after birth.
3
Apply general immunization guidelines for immunocompromised patients.
Live-attenuated vaccines are strictly contraindicated.
Immunocompromised individuals lack the cellular immunity to control live-attenuated viruses, placing them at risk for disseminated vaccine-strain infection.
4
Evaluate the standard 2-month vaccine schedule to identify any live vaccines.
Rotavirus is the only live vaccine on the 2-month schedule.
DTaP, Hib, IPV, and PCV are all inactivated, toxoid, or recombinant subunit vaccines and are safe to administer.
5
Formulate the final management plan.
Withhold the rotavirus vaccine, but give DTaP, Hib, IPV, and PCV.
Inactivated vaccines are safe and essential for protecting the vulnerable infant, while the live rotavirus vaccine poses a life-threatening risk.

Key Concept

Infants exposed to maternal immunosuppressive biologics (like TNF-alpha inhibitors) in utero are considered immunocompromised for the first 6 months of life, making early live vaccines (e.g., rotavirus) contraindicated.
Question 2658Question →

A male neonate is evaluated in the delivery room shortly after an uncomplicated vaginal delivery at 3939 weeks of gestation. The 2828-year-old mother received routine prenatal care, and her standard infectious disease screening was negative. Birth weight is 3,250 g3,250 \text{ g}. Apgar scores were 88 and 99 at 11 and 55 minutes, respectively. The neonate's vital signs are: temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), heart rate 145/min145/\text{min}, and respiratory rate 42/min42/\text{min}. Physical examination is notable for a diffuse skin eruption consisting of numerous 11 to 2 mm2 \text{ mm} fragile vesiculopustules over the chin, posterior neck, lower back, and buttocks. Several of the lesions have already ruptured, revealing hyperpigmented macules with a surrounding fine collarette of scale. The infant is vigorous, with a normal cry and symmetric reflexes. Microscopic examination of the fluid from an intact pustule using a Wright stain demonstrates a large number of polymorphonuclear neutrophils, without any identifiable bacteria, eosinophils, or multinucleated giant cells. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Reassurance and continued routine newborn care

Answer

The correct management is reassurance and continued routine newborn care.
The infant's presentation is highly characteristic of transient neonatal pustular melanosis (TNPM). TNPM is a benign, self-limited vesiculopustular eruption that is most commonly seen in neonates of African descent. Key distinguishing features include its presence immediately at birth, the easy rupture of the pustules, and the characteristic residual hyperpigmented macules with a collarette of scale. Furthermore, a Wright stain of the pustular fluid classically reveals a predominance of polymorphonuclear neutrophils without bacteria. Because TNPM is a physiological variant rather than a pathologic infectious process, it resolves spontaneously over several weeks to months. The appropriate management is strictly supportive with reassurance and routine newborn care. Interventions such as systemic antibiotics or antivirals are contraindicated and needlessly expose the neonate to potential harm.

Step-by-Step Solution

1
Analyze the onset timing of the clinical findings.
The infant is in the delivery room, meaning the vesiculopustular rash was present immediately at birth.
Timing helps differentiate between transient neonatal pustular melanosis (present at birth) and erythema toxicum neonatorum (typically appears at 24 to 72 hours of life).
2
Evaluate the morphology of the rash.
The lesions are fragile vesiculopustules that easily rupture to leave hyperpigmented macules with a collarette of scale.
This specific morphological progression is pathognomonic for transient neonatal pustular melanosis.
3
Interpret the cellular findings from the Wright stain.
The smear shows numerous neutrophils without bacteria, eosinophils, or multinucleated giant cells.
Neutrophils confirm the diagnosis of transient neonatal pustular melanosis, ruling out erythema toxicum neonatorum (which shows eosinophils), bacterial pustulosis (which would show bacteria), and herpes simplex virus (which would show multinucleated giant cells).
4
Determine the appropriate management based on the diagnosis.
Because transient neonatal pustular melanosis is a benign physiological rash, no pharmacological or invasive treatment is required.
Avoiding unnecessary antibiotics, antivirals, and invasive tests is a core principle in managing benign neonatal conditions.

Key Concept

Differentiating transient neonatal pustular melanosis (neutrophils, present at birth, hyperpigmented macules) from erythema toxicum neonatorum (eosinophils, appears at 24-72 hours) and infectious etiologies to prevent unnecessary medical interventions.
Question 2659Question →

A 10-month-old previously healthy female infant is brought to the urgent care facility by her father due to labored breathing. Symptoms began three days prior with nasal congestion and a mild fever. Today, she has been feeding poorly and breathing rapidly. On triage, her temperature is 38.0°C (100.4°F), heart rate is 165/min, respiratory rate is 62/min, and oxygen saturation is 88% on room air. Physical examination is notable for prominent intercostal retractions, head bobbing, and widespread crackles with scattered high-pitched wheezing. Based on the most likely diagnosis, which of the following interventions are indicated for this patient? Select all that apply.

Select all that apply

Show answer & explanation

Answer: Application of supplemental oxygen; Enteral or intravenous fluid rehydration

Answer

The correct interventions are the application of supplemental oxygen and enteral or intravenous fluid rehydration.
The appropriate management strategy for this patient includes the application of supplemental oxygen and fluid rehydration. This infant's presentation is highly characteristic of severe viral bronchiolitis, typified by upper respiratory symptoms that progress to tachypnea, prominent retractions, wheezing, and crackles. Because this patient has significant hypoxemia (oxygen saturation of 88%) and signs of severe respiratory distress (head bobbing) combined with a history of poor feeding, she requires immediate admission. Supplemental oxygen is necessary to maintain saturations safely above 90%, and intravenous or nasogastric fluid rehydration is required to compensate for increased insensible losses and poor oral intake.

Step-by-Step Solution

1
Identify the clinical syndrome from the patient's presentation.
The patient is an infant presenting with a viral prodrome that rapidly progressed to lower respiratory distress (tachypnea, wheezing, and crackles), which is the classic presentation of acute viral bronchiolitis.
Establishing the correct diagnosis prevents the inappropriate use of asthma-specific or bacterial-specific therapies.
2
Assess the severity of the respiratory distress.
The presence of head bobbing, severe tachypnea (62/min), poor feeding, and notable hypoxemia (88%) indicates severe bronchiolitis with impending respiratory failure.
Severity dictates the level of intervention required, distinguishing candidates for outpatient monitoring from those needing hospital admission.
3
Determine the appropriate management bundle.
The standard of care for severe viral bronchiolitis is purely supportive, prioritizing respiratory support with supplemental oxygen to correct hypoxemia and fluids to correct dehydration.
Current pediatric guidelines mandate supportive care while explicitly advising against routine medications like bronchodilators, steroids, and antibiotics.

Key Concept

The cornerstone of management for viral bronchiolitis in infants is supportive care, primarily consisting of supplemental oxygen for hypoxemia and fluid rehydration for poor feeding; bronchodilators, corticosteroids, and antibiotics lack efficacy and are not indicated.
Question 2660Question →

A 31-year-old man returns to the clinic for a follow-up regarding chronic lower back pain. He first developed the pain 1818 months ago. It is characteristically worse in the morning and improves with exercise. Three months ago, he was diagnosed with ankylosing spondylitis based on classic clinical findings and evidence of bilateral sacroiliitis on pelvic radiography. Over the past 3 months, he has undergone consecutive, continuous trials of naproxen and ibuprofen at maximum tolerated doses, along with a daily physical therapy regimen. Today, he reports no significant improvement in his symptoms, complaining of persistent spinal stiffness that lasts for up to 22 hours every morning. He denies any peripheral joint pain, swelling, eye redness, or gastrointestinal symptoms. Vital signs are within normal limits. Physical examination reveals restricted lumbar flexion and tenderness over the sacroiliac joints. Laboratory studies show an erythrocyte sedimentation rate of 45 mm/h45 \text{ mm/h} (Reference: <15 mm/h< 15 \text{ mm/h}) and a C-reactive protein of 22 mg/L22 \text{ mg/L} (Reference: <3 mg/L< 3 \text{ mg/L}). Which of the following is the most appropriate next step in the management of this patient's condition?

Show answer & explanation

Answer: Initiate therapy with etanercept

Answer

Initiate therapy with etanercept
The correct action is to initiate a biologic agent, such as a tumor necrosis factor (TNF) alpha inhibitor (e.g., etanercept, adalimumab, infliximab) or an IL-17 inhibitor. This patient has active ankylosing spondylitis with purely axial involvement that has failed to improve after continuous, adequate trials of multiple nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs are the first-line pharmacotherapy for symptomatic relief; however, if disease activity remains high despite an adequate trial (typically at least 2-4 weeks each of two different NSAIDs), biologic disease-modifying antirheumatic drugs (DMARDs) are indicated to reduce inflammation, improve mobility, and potentially slow radiographic progression.

Step-by-Step Solution

1
Identify the patient's diagnosis and current disease phenotype.
The patient has confirmed ankylosing spondylitis with isolated axial symptoms (morning stiffness, limited lumbar flexion) and elevated inflammatory markers, with no peripheral joint involvement.
Understanding the clinical phenotype (axial versus peripheral) is necessary to guide therapeutic decisions in spondyloarthropathies.
2
Evaluate the patient's prior treatment and response.
He has failed continuous trials of two different NSAIDs (naproxen and ibuprofen) at maximum tolerated doses over a 3-month period, alongside physical therapy.
Guidelines require an adequate trial of at least two NSAIDs before escalating therapy for active ankylosing spondylitis.
3
Determine the appropriate escalation of therapy for purely axial disease.
A biologic DMARD, specifically a TNF-alpha inhibitor (e.g., etanercept) or an IL-17 inhibitor, is indicated.
Conventional synthetic DMARDs (methotrexate, sulfasalazine) are ineffective for axial disease. Biologics are the standard next step to control inflammation and improve functional status.

Key Concept

In patients with ankylosing spondylitis who have purely axial disease and fail to respond to continuous NSAID therapy, the most appropriate next step in management is the initiation of a TNF-alpha inhibitor (e.g., etanercept, adalimumab) or an IL-17 inhibitor. Conventional DMARDs (methotrexate, sulfasalazine) are ineffective for axial disease.
PreviousPage 133 / 414Next